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Background: The consumption of garlic is widely accepted for its beneficial health effects, particularly in regards to the reduction in multiple risk 
factors associated with cardiovascular diseases. Recently, diallyl trisulfide (DATS), an organic polysulfide compound, was identified as a mediator 
of the cardiovascular health benefits attributed to garlic. DATS, along with other garlic-derived organic polysulfides, act as stable hydrogen sulfide 
(H2S) donors when they react with biological thiols such as glutathione. We evaluated the therapeutic potential of DATS in an in vivo murine model 
of myocardial ischemia-reperfusion (MI/R) injury. 
Methods: Mice (C57BL6/J, 8-10 wk old) were subjected to 45 minutes of myocardial ischemia followed by reperfusion for 24 hr. DATS (200 μg/
kg) or Vehicle (saline) was administered intravenously at the time of reperfusion. After 24 hr of reperfusion, serum troponin-I levels were measured, 
and the extent of myocardial infarction per area-at-risk (INF/AAR) or the extent of myocardial infaction per left ventricle (INF/LV) was evaluated with 
2,3,5-Triphenyltetrazolium chloride staining. 
Results: The administration of DATS reduced the INF/AAR by 61% (p<0.001 vs. Vehicle) and the INF/LV by 65% (p<0.001 vs. Vehicle). DATS also 
reduced circulating troponin-I levels from 43.58+/-5.7 ng/mL to 16.38+/-5.0 ng/mL (p=0.003 vs. Vehicle). 
Conclusion: These findings provide novel information regarding the use of the stable H2S donor, DATS, in the treatment of MI/R injury.
